YIF1B
Protein YIF1B
Also known as: FinGER8, YIF1B_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q5BJH7
- Gene
- YIF1B
- Ensembl
- ENSG00000167645
- Chromosome
- 19
- Canonical length
- 314 aa
- Protein class
- Disease related genes, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Golgi apparatus,Vesicles
OverviewNCBI Gene
Involved in endoplasmic reticulum to Golgi vesicle-mediated transport. Located in Golgi apparatus; endoplasmic reticulum; and endoplasmic reticulum-Golgi intermediate compartment. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
314 residues, UniProt reviewed canonical sequence.
>Q5BJH7|YIF1B
1 MHPAGLAAAA AGTPRLRKWP SKRRIPVSQP GMADPHQLFD DTSSAQSRGY GAQRAPGGLS
61 YPAASPTPHA AFLADPVSNM AMAYGSSLAA QGKELVDKNI DRFIPITKLK YYFAVDTMYV
121 GRKLGLLFFP YLHQDWEVQY QQDTPVAPRF DVNAPDLYIP AMAFITYVLV AGLALGTQDR
181 FSPDLLGLQA SSALAWLTLE VLAILLSLYL VTVNTDLTTI DLVAFLGYKY VGMIGGVLMG
241 LLFGKIGYYL VLGWCCVAIF VFMIRTLRLK ILADAAAEGV PVRGARNQLR MYLTMAVAAA
301 QPMLMYWLTF HLVRLocalizationUniProt · AlphaFold · HPA
Whether an antibody against YIF1B can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 5
- Mean surface accessibility (rSASA)
- 0.41
- Highest tissue expression
- 65 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 65 nTPM
- liver: 54 nTPM
- spinal cord: 51 nTPM
- spleen: 46 nTPM
- cerebral cortex: 43 nTPM
- choroid plexus: 42 nTPM
Single-cell type
- platelets: 253 nCPM
- megakaryocytes: 148 nCPM
- hofbauer cells: 116 nCPM
- extravillous trophoblasts: 67 nCPM
- megakaryocyte progenitors: 67 nCPM
- esophageal suprabasal cells: 67 nCPM
Immune cell
- myeloid DC: 301 nTPM
- eosinophil: 180 nTPM
- classical monocyte: 156 nTPM
- plasmacytoid DC: 127 nTPM
- total PBMC: 120 nTPM
- intermediate monocyte: 120 nTPM
Brain region
- white matter: 55 nTPM
- pons: 54 nTPM
- cerebellum: 51 nTPM
- medulla oblongata: 50 nTPM
- thalamus: 46 nTPM
- spinal cord: 44 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about YIF1B.
Disease | AllUniProt
Conditions YIF1B is implicated in, by any mechanism.
- Kaya-Barakat-Masson syndrome (KABAMAS) MIM:619125
Disease | GeneticClinVar
9 pathogenic / likely-pathogenic of 90 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Kaya-Barakat-Masson syndrome
- Inborn genetic diseases
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.1
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.4
- DepMap mean gene effect
- -0.03
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 8% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- endoplasmic reticulum to Golgi vesicle-mediated transport
- protein targeting to membrane
- protein transport
- sperm flagellum assembly
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of YIF1B in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads YIF1B as an antibody target. Whether an autoantibody or antibody against YIF1B could matter depends on whether native YIF1B is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
YIF1B is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label YIF1B as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...